These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 9061303)
1. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma. Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303 [TBL] [Abstract][Full Text] [Related]
2. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic. Roudovitch N; Nauck MA; Schatz H; Pfeiffer AF Exp Clin Endocrinol Diabetes; 2001; 109(8):397-401. PubMed ID: 11748487 [TBL] [Abstract][Full Text] [Related]
3. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE; Matthews DR Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [TBL] [Abstract][Full Text] [Related]
4. Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma. Kim CH; Park JY; Shong YK; Hong SK; Kim GS; Lee KU Clin Endocrinol (Oxf); 2000 Jan; 52(1):87-92. PubMed ID: 10651758 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients. Nauck M; Stöckmann F; Creutzfeldt W Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348 [TBL] [Abstract][Full Text] [Related]
6. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism. Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180 [TBL] [Abstract][Full Text] [Related]
7. [Differences in insulin secretion facilitate the differential diagnosis of insulinoma and factitious hypoglycaemia]. Meier JJ; Hücking K; Grüneklee D; Schmiegel W; Nauck MA Dtsch Med Wochenschr; 2002 Feb; 127(8):375-8. PubMed ID: 11859446 [TBL] [Abstract][Full Text] [Related]
8. Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma. Battezzati A; Terruzzi I; Perseghin G; Bianchi E; Di Carlo V; Pozza G; Luzi L Diabetes; 1995 Jul; 44(7):837-44. PubMed ID: 7789652 [TBL] [Abstract][Full Text] [Related]
9. C-peptide during the prolonged fast in insulinoma. Service FJ; O'Brien PC; McMahon MM; Kao PC J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021 [TBL] [Abstract][Full Text] [Related]
10. [Hypoglycemic and hyperinsulinemic clamp technic to determine the secretory behavior of insulinoma]. Hütter R; Irsigler K; Vesely M; Ogris E Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1146-8. PubMed ID: 2839328 [TBL] [Abstract][Full Text] [Related]
11. How reliable is the euglycaemic hyperinsulinemic clamp test for the confirmation of autonomous endogenous hyperinsulinemia? Mićić D; Popović V; Sumarac M; Kendereski A; Nesović M; Djordjević P; Manojlović D; Mićić J Exp Clin Endocrinol; 1990 Apr; 95(2):242-50. PubMed ID: 2163878 [TBL] [Abstract][Full Text] [Related]
12. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia. Cotterill AM; Holly JM; Amiel S; Wass JA Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525 [TBL] [Abstract][Full Text] [Related]
13. Assessment of hyperinsulinaemia at the termination of the prolonged fast. Wiesli P; Brändle M; Zapf J; Seiler H; Zwimpfer C; Spinas GA; Schmid C Clin Chim Acta; 2004 Apr; 342(1-2):227-31. PubMed ID: 15026285 [TBL] [Abstract][Full Text] [Related]
14. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma. Hiramatsu S; Sako Y; Mimura K; Ono Y; Iwashige K; Taniguchi S; Umeda F; Nawata H Endocr J; 1995 Feb; 42(1):39-42. PubMed ID: 7599696 [TBL] [Abstract][Full Text] [Related]
15. Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action. Vigili de Kreutzenberg S; Riccio A; Dorella M; Avogaro A; Marescotti MC; Tiengo A; del Prato S Eur J Clin Invest; 1995 May; 25(5):360-7. PubMed ID: 7628524 [TBL] [Abstract][Full Text] [Related]
16. Increased plasma β-hydroxybutyrate levels during the fasting test in patients with endogenous hyperinsulinaemic hypoglycaemia. Buffet A; Vezzosi D; Maiza JC; Grunenwald S; Bennet A; Caron P Eur J Endocrinol; 2013 Jul; 169(1):91-7. PubMed ID: 23657581 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of insulin secretion patterns in insulinoma. Saddig C; Goretzki PE; Starke AA World J Surg; 2008 May; 32(5):918-29. PubMed ID: 18259806 [TBL] [Abstract][Full Text] [Related]
18. Failure to suppress C-peptide secretion by euglycaemic hyperinsulinaemia: a new diagnostic test for insulinoma? Yki-Järvinen H; Pelkonen R; Koivisto VA Clin Endocrinol (Oxf); 1985 Oct; 23(4):461-6. PubMed ID: 2998651 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas. Nauck MA; Meier JJ Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166 [TBL] [Abstract][Full Text] [Related]